ArticleFrontiers in medicine2022

A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program.

Kristin Karlsdottir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.